DadFinStart your free week
DadFin › Stocks › Technology › CNXC

Concentrix Corporation (CNXC) stock score

Technology · Information Technology Services · United States

$25.95 ▼ -4.14% today

15.5
Dad Score, out of 100
weak

Concentrix Corporation (CNXC) is a Information Technology Services company in the Technology sector, listed in the United States. On DadFin's weekly run it scores 15.5 out of 100 on the Dad Score, a weak reading that places the business ahead of 16% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Technology it ranks #639 of 780. Its strongest axes are valuation, conviction and liquidity; its weakest are quality and growth.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Weak
Growth
Weak
Price action
Weak
Risk
Weak
Conviction
Above average
Liquidity
Above average
Macro
Weak

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)2.1×
Dividend yield5.33%
Return on capital-10.4%
Operating margin5.7%
Revenue growth (YoY)+2.2%
FCF yield9.8%
Net debt / EBITDA3.62×
Piotroski F-Score4 / 9
52-week change-45.1%
Market cap$1.5B
Next earningsJan 13, 2027

What subscribers see on CNXC

Start your free weekSubscriber? Open the full research →

Information Technology Services peers

StockCompanyDad ScoreBandMarket cap
IBMInternational Business Machines Co69.6middling$209.8B
ACNAccenture plc93.3strong$121.7B
INFYInfosys Limited51.8middling$44.7B
CTSHCognizant Technology Solutions Cor64.9middling$27.7B
BRBroadridge Financial Solutions, In74.9good$17.7B
WITWipro Limited32.7weak$17.0B
FISFidelity National Information Serv54.3middling$16.8B
CDWCDW Corporation87.7strong$16.7B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.